Development of an in vivo mouse model to study oral submucous fibrosis

Journal of Oral Pathology and Medicine

Volumn 36, Issue 5, 2007, Pages 273-280

  Sumeth Perera, M W ^a   Gunasinghe, D ^a   Perera, P A J ^a   Ranasinghe, A ^b   Amaratunga, P ^b   Warnakulasuriya, S ^c   Kaluarachchi, K ^a  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Areca nut; Epithelial atropy; Mouse model; Oral submucous fibrosis

Indexed keywords

SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BETEL NUT; CELL INFILTRATION; CHEEK MUCOSA; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; FIBROBLAST; IN VIVO STUDY; INFLAMMATORY CELL; MICROSCOPY; MOUSE; MOUTH DISEASE; MOUTH MUCOSA; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; ARECA; FEMALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MOUTH MUCOSA; ORAL SUBMUCOUS FIBROSIS;

EID: 34247368125     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00523.x     Document Type: Article

References (45)

1. International Agency for Research on Cancer. WHO classification of tumours: pathology and genetics of head and neck tumours. Eds: Barnes L, Eveson JW, Reichart PA, Sidransky D. Lyon: IARC Press, 2005 181.
2. Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol 2002 7: 77 83.
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines, Vol. 85. Lyon: International Agency for Research on Cancer, 2004.
4. Raghavan V, Baruah HK. Arecanut: India's popular masticatory- History, chemistry and utilization. Econ Bot 1958 12: 315 25.
5. Huang JL, McLeish MJ. HPLC determination of the alkaloids in betel nut. J Chromatogr 1989 475: 447 50.
6. Lord GA, Lim CK, Warnakulasuriya S, Peters TJ. Chemical and analytical aspects of areca nut. Addict Biol 2002 7: 99 102.
7. Daftary DK, Murti PR, Bhonsle RB, Gupta PC, Mehta FS, Pindborg JJ. Oral precancerous lesions and conditions of tropical interest. In: Prabhu SR, Wilson DR, Daftary DK, Johnson NW, eds. Oral diseases in the tropics. Delhi: Oxford University Press, 1993 402 28.
8. Zain RB, Ikeda N, Gupta PC et al. Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. J Oral Pathol Med 1999 28: 1 4.
9. Johnson NW, Maher R, Trivedy C, Warnakulasuriya S. The clinical condition and pathology of oral submucous fibrosis (OSF). Oral Dis 1997 3: 278 9.
10. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966 22: 764 79.
11. Huang S, Ling T, Wu H. Experimental study on aqueous areca nut extracts inducing oral submucous fibrosis in rats. I. Observations of histomorphometry. HuaXiKouQiangYi XueZaZhi 1997 15: 91 3, 96.
12. Khrime RD, Mehra YN, Mann SBS, Mehta SK, Chakraborti RN. Effects of instant preparation of betel nut (pan masala) on the oral mucosa of albino rats. Indian J Med Res 1991 94: 119 24.
13. Bancroft JD, Cook HC. Manual of histological techniques and their diagnostic application. New York: Churchill Livingstone, 1994.
14. Maher R, Lee AJ, Warnakulasuriya KAAS, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis - a case control study in Pakistan. J Oral Pathol Med 1994 23: 65 9.
15. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta MC. Oral submucous fibrosis in India: a new epidemic? Natl Med J India 1998 11: 113 6.
16. Sinor PN, Gupta PC, Murti PR et al. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 1990 19: 94 8.
17. Bhide SV, Shivapurkar NM, Gothoskar SV, Ranadive KJ. Carcinogenicity of betel quid ingredients: feeding mice with aqueous extract and the polyphenols fraction of betel nut. Br J Cancer 1979 40: 922 6.
18. Bhisey RA, Ramchandani AG, D'Souza AV, Borges AM, Notani PN. Long-term carcinogenicity of pan masala in Swiss mice. Int J Cancer 1999 83: 679 84.
19. Mehta AR, Bokil KP, Chandavarkar RY. Pre-cancerous lesion in the oral cavity. In: Rao RS, Desai PB, eds. Oral cancer. Bombay: Tata Memorial Centre, 1991 24 40.
20. Roach HI, Shearer JR, Archer C. The choice of an experimental model: a guide for research workers. J Bone Joint Surg Br 1989 71: 549 53.
21. Warnakulasuriya KA, MacDonald DG. Epithelial cell kinetics in oral leukoplakia. J Oral Pathol Med 1995 24: 165 9.
22. Ranasinghe AW, Warnakulasuriya KAAS, Tennekoon GE, Seneviratna B. Oral mucosal changes in iron deficiency anaemia in a Sri Lankan female population. Oral Surg Oral Med Oral Pathol 1983 55: 29 32.
23. Jafarey NA, Zaidi SHM. Carcinoma of the oral cavity and oropharynx in Karachi (Pakistan). An appraisal. Trop Doct 1976 6: 63 7.
24. Pindborg JJ, Mehta FS, Daftary DK. Occurrence of epithelial atypia in 51 Indian villagers with oral submucous fibrosis. Br J Cancer 1970 24: 253 7.
25. Hamner JE, Mehta FS, Pindborg JJ, Daftary DK. Altered staining reaction of connective tissues in 53 submucous fibrosis patients. J Dent Res 1971 50: 388 92.
26. Pindborg JJ, Bhonsle RB, Murti PR, Gupta PC, Daftary DK, Mehta FS. Incidence and early forms of oral submucous fibrosis. Oral Surg 1980 50: 40 4.
27. Ioachim E, Charchanti A, Briasoulis E et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV, and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 2002 38: 2362 70.
28. Boudreaw NJ, Jones PL Extracellular matrix and integrin signaling: the shape of things to come. Biochem J 1999 339: 481 8.
29. Reichart PA, van Wyk CW, Becker J, Schuppan D. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF). J Oral Pathol Med 1994 23: 394 8.
30. Pindborg JJ. Oral submucous fibrosis: a review. Ann Acad Med Singapore 1989 18: 603 7.
31. Warnakulasuriya S. Semi-quantitative clinical description of oral submucous fibrosis. Ann Dent 1987 46: 18 21.
32. Rajendran R, Sunil A, Twinkle SP, Anilkumar TV, Anne J. Cell death does not herald epithelial involution (''atrophy'') in oral submucous fibrosis: a TEM study. Ind J Dent Res 2004 15: 13 9.
33. van Wyk CW, Seedat HA, Phillips VM. Collagen in submucous fibrosis: an electron-microscopic study. J Oral Pathol Med 1990 19: 182 7.
34. Utsunomiya H, Tilakaratne WM, Oshiro K et al. Extracellular matrix remodelling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridisation. J Oral Pathol Med 2005 34: 498 507.
35. Canniff JP, Harvey W. The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 1981 10: 163 7.
36. van Wyk CW, Oliver A, Hoal-van Helden EG, Grobler-Rabie AF. Observations on the effect of areca nut extracts on oral fibroblasts proliferation. J Oral Pathol Med 1994 23: 145 8.
37. Trivedy C, Baldwin D, Warnakulasuriya S, Johnson NW, Peters TJ. Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 1997 340: 1447.
38. Rajalalitha P, Vali S. Molecular pathogenesis of oral of submucous fibrosis - a collagen metabolic disorder. J Oral Pathol Med 2005 34: 321 8.
39. Sirsat SM, Pindborg JJ. Mast cell responses in early and advance oral submucous fibrosis. Acta Pathol Microbiol Scand 1967 70: 174 8.
40. Sirsat SM, Khanolkar VR. Submucous fibrosis of the palate: induction by local painting of capsaicin in Wistar rats treated with desoxycorticosterone acetate - an optical and electron microscopic study. Arch Pathol 1960 70: 180 7.
41. Jeng JH, Lan WH, Hahn LJ, Hsieh CC, Kuo MY. Inhibition of the migration, attachment, spreading, growth and collagen synthesis of human gingival fibroblasts by arecoline, a major areca alkaloid, in vitro. J Oral Pathol Med 1996 25: 371 5.
42. Jeng JH, Kuo ML, Hahn LJ, Kuo MY. Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res 1994 73: 1043 9.
43. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006 42: 561 8.
44. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factor in oral submucous fibrosis. Cytokine 1998 10: 713 9.
45. El-Labban NG, Canniff JP. Ultrastructural finding of muscle degeneration in oral submucous fibrosis. J Oral Pathol 1985 14: 709 17.